Table 2

Patients receiving depleting therapies

Patients

n

Agea range (median; years)

Sex (male/female)

Graft manipulation


RA cohort 1

9

32–61 (42)

2/7

Unmanipulated

RA cohort 2

16

43–55 (47)

4/12

CD34 selection

RA cohort 3

6

24–61 (39)

3/3

CD34 selection, T-cell depletion

Solid tumours

7

39–64 (44)

2/5

Unmanipulated

Lymphoma/sarcoma

7

22–64 (46)

5/2

Unmanipulated

Systemic vasculitis (depleting antibody therapy)

3

43–61 (52)

2/1

Not applicable


aAge at time of transplantation. RA, rheumatoid arthritis.

Ponchel et al. Arthritis Res Ther 2005 7:R80-R92   doi:10.1186/ar1452

Open Data